Drug Shortage Report for RAN-RANITIDINE

Last updated on 2018-08-23 History
Report ID 12310
Drug Identification Number 02336502
Brand name RAN-RANITIDINE
Common or Proper name RAN-RANITIDINE
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status DORMANT
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-02-02
Actual start date 2017-02-02
Estimated end date
Actual end date 2018-08-17
Shortage status Resolved
Updated date 2018-08-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-06-08 English Compare
v2 2017-06-08 French Compare
v3 2017-07-18 English Compare
v4 2017-07-18 French Compare
v5 2017-07-19 English Compare
v6 2017-07-19 French Compare
v7 2018-08-23 English Compare
v8 2018-08-23 French Compare

Showing 1 to 8 of 8